CASZ1 and hepatocellular carcinoma: For instance, Wang et al. reported reduced CASZ1 expression in hepatocellular carcinoma tissues, which hindered abnormal tumor cell proliferation by modulating the MAPK/ERK signaling pathway alongside MMP2 and MMP9 expression in vitro [74].